
October 2014 Vol. 3 Issue
10
Other viewing option
Abstract
•
Full
text
•Reprint
(PDF) (400 KB)
Search Pubmed for articles by:
Nassar AY
Nassar MY
Other links:
PubMed Citation
Related articles in PubMed
|
|
Global Advanced Research Journal
of Medicine and Medical Sciences (GARJMMS) ISSN: 2315-5159
October 2014 Vol. 3(10), pp.
298-307
Copyright © 2014 Global Advanced
Research Journals
Full Length Research Paper
Copper (I)-Nicotinate Complex Promoted the Synthesis
of Aflatoxin M1 and Q1 More Efficiently than
Butylated hydroxytoluene in Afaltoxicosed Rats
Ahmed Y. Nassar1, Ahmed M. Ali2*,
Mona A. El-Baz1, Heba M. Saad Eldien3,
Yousif S. Mohamed4, Fathy F. Abdel Latif4,
Abdel Haleem M. Hussein2 and Muammar Y.
Nassar5
1Department
of Biochemistry, Faculty of Medicine, Assiut
University, Egypt
2Department
of Chemistry, Faculty of Science, Al-Azhar
University, Assiut Branch, Egypt.
3Department
of Histology, Faculty of Medicine, Assiut
University, Egypt
4Department
of Chemistry, Faculty of Science, Minia University,
Egypt
5Department
of Biochemistry, Dongola University, Sudan
*Corresponding Author E-mail:
ahmedshatat82@yahoo.com; Phone: 002
01006785228
Accepted 07 October, 2014
|
Abstract |
In a previous work we have reported that synthetic
copper (I)-nicotinate complex efficiently prevented
induced nephrotoxicity by Aflatoxin B1 (AFB1)
specifically by promoting phase II detoxificating
glutathione-S-transferase activity. This work has
been conducted to evaluate the antitoxic effect of
the complex on the metabolism of AFB1. Forty five
healthy male Wister albino rats were intoxicated (20
μg/kg B.W.) day after day for five weeks. The
individually collected urine was assayed for AFB1,
AFM1 and AFQ1 contents by HPLC technique. One third
of them were co-treated by butylated hdroxytoluene (BHT)
(0.05 g/kg B.W.), the second was co-treated by the
copper complex (400 μg/kg B.W.) while the last was
only intoxicated untreated group. Significant
increase in the less toxic AFM1 and AFQ1 metabolites
was recorded by any of the co-treating agents. The
output of the least toxic AFQ1 fraction was
significantly increased by the copper complex as
regard to the BHT, (P <0.05). Conclusively, AFM1 and
AFQ1 fractions in the urine that were promoted by
the two tested agents may be related to their
potentiating activity upon the phase I
detoxificating CYP 1A2 and 3A4 enzyme families
respectively. The significantly increased detoxified
AFQ1 metabolite may be preferentially promoted by
the copper (I)-nicotinate complex. This beneficial
detoxificating effect of the copper complex has been
obviously confirmed by observed great reduction in
the immunohistochemical detection of vascular
endothelial growth factor that was highly initiated
by aflatoxicosis. Hence, such a complex could be
saftly accepted as a highly potent antitoxic agent
against aflatoxicosis
Keywords:
Butylated hydroxytoluene, Copper(I)-nicotinate
complex, Aflatoxin Q1, Aflatoxicosis,
Chemoprotectant, Antioxidant
|
|
|